Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Multicenter Observational Study of Irinotecan Utilized in Mono- or Combination Therapy for the Treatment of Advanced Colorectal Carcinoma.

NCT01840280 is registered in ClinicalTrials.gov with Onkovis GmbH as lead sponsor.

NCT NCT01840280
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01840280 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Multicenter Observational Study of Irinotecan Utilized in Mono- or Combination Therapy for the Treatment of Advanced Colorectal Carcinoma.
Lead sponsor
Onkovis GmbH
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
April 30, 2018
Enrollment
324 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma